Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Ünal Ç, Azizy A, Karabulut S, Taştekin D, Akyıldız A, Yaşar S, Yalçın Ş, Çoban E, Evrensel T, Kalkan Z, Oruç Z, Derin S, Turna ZH, Bayram D, Köş FT, Şendur MAN, Sever N, Ercelep Ö, Seyyar M, Kefeli U, Uygun K, Özçelik M, Ön S, Şanlı UA, Canaslan K, Ünek İT, Yücel KB, Özdemir N, Yazıcı O, Güzel HG, Salim DK, Göksu SS, Tatlı AM, Ordu Ç, Selvi O, Sakin A, Büyükbayram ME, Dursun B, Ürün Y, Arak H, Ağdaş G, Uğraklı M, Hendem E, Eryılmaz MK, Bilgin B, Topçu A, Şimşek M, Büyükşimşek M, Akay B, Erdal GŞ, Karataş F, Alan Ö, Çağlayan M, Kahvecioğlu FA, Demirci A, Paksoy N, Çetin B, Gümüş M, Ak N, Aydınalp Y, Paydaş S, Güven DC, Kılıçkap S, Sağlam S. Ünal Ç, et al. Among authors: kos ft. Oncologist. 2023 Oct 3;28(10):875-884. doi: 10.1093/oncolo/oyad257. Oncologist. 2023. PMID: 37676712 Free PMC article.
Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.
Kahraman S, Bardakci M, Aykan MB, Yasar S, Erol C, Hizal M, Akinci MB, Kos FT, Kos T, Dede DS, Karadurmus N, Yalcin S, Sendur MAN, Yalcin B. Kahraman S, et al. Among authors: kos t, kos ft. J Cancer Res Ther. 2023 Jan-Mar;19(2):347-354. doi: 10.4103/jcrt.jcrt_353_22. J Cancer Res Ther. 2023. PMID: 37006071 Free article.
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study.
Oktar O, Korkmaz V, Tokalıoğlu A, Öztürk Ç, Erdoğan Ö, Uçar Y, Koca Yıldırım HE, Hanedan C, Kılıç F, Ersak B, Yalçın N, Özmen F, Kahraman A, Esen SA, Baş S, Özdaş ED, Selçuk İ, Uçar G, Koçak Ö, Çakır C, Koç S, Kılıç Ç, Cömert GK, Üreyen I, Toptaş T, Narin MA, Taşçı T, Taşkın S, Boran N, Sancı M, Köş FT, Tekin ÖM, Üstün YE, Ortaç F, Turan T. Oktar O, et al. Among authors: kos ft. J Gynecol Oncol. 2024 May;35(3):e39. doi: 10.3802/jgo.2024.35.e39. Epub 2023 Dec 20. J Gynecol Oncol. 2024. PMID: 38156722 Free PMC article.
32 results